Skip to main content

Table 1 Risk of intussusception following rotavirus vaccination

From: Vaccination ecosystem health check: achieving impact today and sustainability for tomorrow

Vaccine

Phase III Clinical Trial

Post introduction

Rotateq

RR = 1.6 (95% CI: 0.4–6.4) [10]

RR = 9.9 (95% CI: 3.7–26.4) [11]

Rotarix

RR = 0.86 (p = ns) [12]

RR = 6.8 (95% CI:2.4–19.0) [11]

  1. RR Relative risk, CI Confidence interval, ns not statistically significant
Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us